Vascular parkinsonism is a form of parkinsonism caused by cerebrovascular disease rather than the progressive dopamine-cell loss that defines idiopathic Parkinson’s disease. It accounts for a meaningful share of all parkinsonism cases, and its hallmark is a walking difficulty that hits the legs far more than the arms, earning it the informal label “lower body parkinsonism.” The condition is both underdiagnosed and overdiagnosed, because the vascular damage it relies on is common in the same age group that develops Parkinson’s, and telling the two apart can be genuinely difficult.
What Causes It
The underlying damage usually comes from small vessel disease in the brain, particularly lacunar infarcts and extensive deep white matter lesions (often called leukoaraiosis). These tiny strokes tend to cluster in the frontal lobes, the basal ganglia, and the parietal white matter, disrupting the circuits that plan and execute movement.1PubMed. The clinical spectrum of freezing of gait in atypical parkinsonism Structural MRI typically shows brain atrophy alongside widespread white matter lesions, though direct damage to the nigrostriatal pathway itself is uncommon.2PubMed. Vascular parkinsonism: an update That distinction matters: in Parkinson’s disease, the dopamine-producing neurons in the substantia nigra degenerate. In vascular parkinsonism, those neurons are often still intact. The problem is that the wiring connecting them to the rest of the movement circuitry has been severed or disrupted by vascular injury.3PubMed Central. Movement Disorders Following Cerebrovascular Lesion in the Basal Ganglia Circuit
Because the damage stems from cerebrovascular disease, the usual cardiovascular risk factors drive it: hypertension, diabetes, high cholesterol, smoking, and atrial fibrillation. In early studies that helped define the condition, hypertension stood out as far more common in vascular parkinsonism patients than in matched Parkinson’s patients.4PubMed. Lower body parkinsonism: evidence for vascular etiology Managing those risk factors aggressively is one of the few preventive strategies that makes physiological sense, even though no randomized trial has tested whether, say, better blood pressure control slows the progression of vascular parkinsonism specifically.
How It Typically Presents
Two main onset patterns exist, and they look quite different from each other. The more common one is an insidious, slowly progressive decline: walking speed drops, steps get shorter, balance worsens, and the person may develop urinary urgency, difficulty swallowing, or subtle cognitive changes over months to years.5Advances in Clinical Neuroscience and Rehabilitation. Vascular Parkinsonism Because there is no single dramatic event, the person and their family may chalk it up to “getting old” for a long time before seeking help.
The less common pattern is an acute or subacute onset following a clinically obvious stroke. Someone has a stroke, and once the acute phase settles, they are left with parkinsonian features that may stabilize or partially improve. An expert working group has formalized these into three recognized subtypes: the post-stroke subtype, the insidious-onset subtype, and a mixed or overlapping subtype where vascular parkinsonism coexists with true Parkinson’s disease or another neurodegenerative parkinsonism.6PubMed Central. An updated diagnostic approach to subtype definition of vascular parkinsonism – Recommendations from an expert working group That third category is especially tricky. Incidental vascular lesions in the brains of people who actually have Parkinson’s disease are common, so a brain scan showing white matter lesions does not by itself prove vascular parkinsonism.
How It Differs from Parkinson’s Disease
The classic comparison is useful because most people who hear “parkinsonism” immediately think of Parkinson’s disease. The differences are real and clinically significant, though the overlap keeps neurologists up at night.
In Parkinson’s disease, symptoms usually start on one side of the body with a resting tremor or slowed hand movements, and the gait problems come later. In vascular parkinsonism, the pattern is reversed. Walking difficulty is often the first and most prominent symptom, showing up in roughly 90% of cases as the initial complaint.7PubMed. Lower body parkinsonism: evidence for vascular etiology The gait itself is different too: the short, shuffling steps look superficially similar, but the stance is wider based and the stride length varies more, creating what clinicians sometimes call a “parkinsonian-ataxic” gait. Festination, the involuntary acceleration of steps that people with Parkinson’s struggle with, is typically absent in vascular parkinsonism.8PubMed. Vascular parkinsonism: what makes it different?
A systematic review comparing the two conditions found that vascular parkinsonism patients tend to be older at onset, have a shorter duration of illness at presentation, and are more prone to postural instability, falls, and cognitive decline. Pyramidal signs (indicating damage to the motor pathways from the brain to the spinal cord), pseudobulbar palsy, and urinary incontinence are all more common. Tremor, the symptom most associated with Parkinson’s in the public imagination, is not a main feature of vascular parkinsonism.9PubMed. Differentiating vascular parkinsonism from idiopathic Parkinson’s disease: a systematic review A more recent case-control study confirmed this profile and added that vascular parkinsonism patients tend to show more symmetric involvement and lower-half predominance, in contrast to the asymmetric, upper-body-first pattern of Parkinson’s.10PubMed Central. The clinical and neuroimaging differences between vascular parkinsonism and Parkinson’s disease: a case-control study
Freezing of Gait and Falls
Freezing of gait, the sudden inability to lift your feet from the floor despite intending to walk, affects roughly half of vascular parkinsonism patients.11PubMed. The clinical spectrum of freezing of gait in atypical parkinsonism Combined with the early postural instability that characterizes the condition, this makes falls a constant concern. Unlike in Parkinson’s disease, where falls become more dangerous as the disease advances over many years, falls in vascular parkinsonism often appear early and persist. The practical consequence is that fall prevention, including home modifications, assistive devices, and gait-focused rehabilitation, matters from the start rather than becoming a concern only later in the course.
The Role of Brain Imaging
Structural MRI is the backbone of the workup. Doctors look for widespread white matter hyperintensities, lacunar infarcts, and brain atrophy, particularly in the frontal and subcortical regions. But these findings are present to some degree in many older adults, so their mere existence does not clinch the diagnosis. The key is correlating the location and severity of vascular changes with the clinical picture.
Dopamine transporter (DaT) imaging offers a different angle. In Parkinson’s disease, the dopamine-producing cells are dying, so a DaT scan shows markedly reduced uptake in the striatum. In the insidious-onset form of vascular parkinsonism, where the dopamine neurons are largely preserved, the DaT scan is often normal or near-normal. A meta-analysis found that DaT imaging can distinguish Parkinson’s disease from vascular or drug-induced parkinsonism with sensitivity above 85% and specificity above 80%.12PubMed. [¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson’s disease and vascular or drug-induced parkinsonisms: a meta-analysis A normal DaT scan in someone with parkinsonian features and vascular risk factors tilts the diagnosis toward vascular parkinsonism. DaT imaging also helps predict which patients might respond to levodopa, since those with reduced dopamine transporter uptake are more likely to benefit.13PubMed Central. Neuroimaging in Vascular Parkinsonism
The picture is not always clean, however. Patients with asymmetric basal ganglia lesions from stroke can show DaT scan findings that mimic Parkinson’s disease, with asymmetric reduced uptake that looks like dopamine cell loss even though the cause is vascular.14eNeurologicalSci. Vascular parkinsonism showing dopamine transporter scan findings mimicking those of Parkinson’s disease This is one reason diagnosis remains a clinical judgment call, not a matter of plugging scan results into a formula.
Conditions That Mimic Vascular Parkinsonism
Beyond the distinction from Parkinson’s disease, two other conditions deserve mention because they can look strikingly similar.
Idiopathic normal pressure hydrocephalus (iNPH) shares the same triad of gait difficulty, cognitive decline, and urinary incontinence that vascular parkinsonism often produces. It also shows up on imaging with enlarged ventricles and white matter changes that overlap with what you see in small vessel disease. One study found that many patients who had been clinically identified as having vascular parkinsonism with enlarged ventricles actually showed the cerebrospinal fluid pressure patterns characteristic of iNPH. In other words, some people labeled with vascular parkinsonism may actually have treatable hydrocephalus.15PubMed. Vascular parkinsonism or idiopathic NPH? New insights from CSF pressure analysis Since iNPH can be treated with a shunt procedure, missing this diagnosis has real consequences.
Progressive supranuclear palsy (PSP) is another lookalike, especially in its early stages when prominent postural instability and falls are the main features. MRI measurements of brainstem structures can help distinguish the two. The magnetic resonance parkinsonism index (a ratio derived from midbrain and pons measurements) is significantly larger in PSP, and one study found that a threshold value distinguished PSP from vascular parkinsonism with perfect sensitivity and specificity in a small sample.16PubMed. Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism A separate study confirmed that brainstem measurements differed reliably between the two conditions, although the index could not distinguish vascular parkinsonism from Parkinson’s disease.17PubMed. MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson’s disease
Why Levodopa Usually Does Not Help Much
This is the part that frustrates patients and families the most. Levodopa is the gold-standard medication for Parkinson’s disease, and it works by supplementing the dopamine that dying neurons can no longer produce. In vascular parkinsonism, the dopamine neurons are often intact; the problem is the downstream circuitry. Giving more dopamine to cells that are already producing enough does not fix a wiring problem. As a result, vascular parkinsonism is generally considered poorly responsive to levodopa.18PubMed Central. Vascular Parkinsonism: A Review on Management updates
There is an important caveat, though. The post-stroke subtype, which tends to present with asymmetric symptoms, responds better to levodopa than the insidious-onset subtype does.19PubMed Central. An updated diagnostic approach to subtype definition of vascular parkinsonism – Recommendations from an expert working group And a systematic review of treatment evidence found that a subgroup of vascular parkinsonism patients does respond well. Neuroimaging techniques and olfactory identification tests can help identify these responders before a prolonged and futile medication trial.20PubMed Central. Treatment of Vascular Parkinsonism: A Systematic Review This makes intuitive sense: if someone has mixed pathology, with both vascular damage and some degree of dopamine cell loss, the dopamine-replacement component of their symptoms might still respond. The practical takeaway is that a trial of levodopa is still worth attempting, but expectations should be calibrated. A dramatic response makes coexisting Parkinson’s disease more likely; a poor response does not mean the diagnosis is wrong.
Rehabilitation as a Central Strategy
Because medication options are limited, structured rehabilitation takes on an outsized role in managing vascular parkinsonism. This is a shift in mindset for people accustomed to thinking of neurological conditions as primarily medication-managed. The evidence base is still thin in terms of large trials, but case-level studies have shown encouraging results.
Body weight-supported treadmill training, where a harness partially offloads the person’s weight while they walk on a treadmill, improved gait-related outcomes in a patient with vascular parkinsonism secondary to multiple cerebral infarctions.21Physical Therapy Research. Effects of Body Weight-supported Treadmill Training in a Patient with Vascular Parkinsonism Secondary to Multiple Cerebral Infarctions: A Single-case Design Task-oriented circuit training, which focuses on high repetitions of functional movements with progressive challenge, led to improvements in balance, walking endurance, pain, and quality of life over a six-week program in another case study.22Indonesian Journal of Physical Medicine and Rehabilitation. Functional Outcomes of Task-Oriented Circuit Training in a Middle-Aged Male with Vascular Parkinsonism and Recurrent Stroke: A Case Report These are single-case designs, and larger studies are needed before any rehabilitation protocol can be recommended with confidence. But the rationale is sound: the motor circuits are disrupted but not destroyed, and repetitive, task-specific training may help the brain recruit alternative pathways.
Cardiovascular risk factor management deserves emphasis as part of the overall treatment approach. Controlling blood pressure, managing diabetes, addressing cholesterol, and stopping smoking do not reverse existing vascular damage, but they reduce the odds of additional small vessel events that could worsen the parkinsonism over time.
Cognitive and Psychiatric Features
Vascular parkinsonism does not only affect movement. The same small vessel disease that disrupts motor circuits also damages frontal-subcortical connections involved in executive function, motivation, and emotional regulation. The result is a cognitive profile that looks different from the memory-first decline of Alzheimer’s disease. Word generation, mental flexibility, and processing speed tend to be hit earliest and hardest.23Dementia. Vascular Subcortical Dementias: Clinical Aspects
Apathy is the psychiatric feature that flies under the radar most often. In cerebral small vessel disease, about 28% of patients meet criteria for apathy, roughly three times the rate in healthy controls, while depression rates are not significantly different between groups.24PubMed Central. Apathy, but not depression, is associated with executive dysfunction in cerebral small vessel disease The distinction matters because apathy looks like depression to families and even to clinicians, but it does not respond to antidepressants in the same way. A person with apathy is not necessarily sad; they simply lack the drive to initiate activities. The person who used to enjoy gardening or socializing now sits and does nothing, not because they feel hopeless, but because the motivational circuits in their frontal lobes have been disrupted. Recognizing this as a consequence of vascular brain injury, rather than a psychological reaction to disability, changes how you approach it.
Pain as an Overlooked Symptom
Pain is common across all forms of parkinsonism, but its pattern varies. In vascular parkinsonism, pain typically precedes the onset of motor symptoms, a temporal pattern shared with Parkinson’s disease and multiple system atrophy. This stands in contrast to progressive supranuclear palsy, where pain more often follows motor symptoms. The body distribution of pain also differs across these conditions.25PubMed. Pain in atypical parkinsonism, vascular parkinsonism, and Parkinson’s disease For someone living with vascular parkinsonism, pain that appeared before the walking problems started may not be recognized as part of the same condition. Mentioning it to the neurologist is worthwhile, because addressing pain can improve mobility and quality of life even when the underlying parkinsonism itself cannot be reversed.
Autonomic Nervous System Involvement
The autonomic nervous system controls involuntary functions like heart rate, blood pressure regulation, and digestion. In Parkinson’s disease, autonomic dysfunction is well established and can include constipation, blood pressure drops on standing, and bladder problems. Vascular parkinsonism can produce its own set of autonomic disturbances, though the pattern is not identical. Research measuring heart rate variability found a decreased coefficient of variation in the R-R interval in vascular parkinsonism patients compared to controls, suggesting reduced cardiac autonomic control, even though standard standing blood pressure tests did not show a significant difference between groups. This means the autonomic involvement may be subtler and detectable only with more sensitive testing.
Urinary dysfunction is particularly common in vascular parkinsonism and can appear early, unlike in Parkinson’s disease where it tends to emerge later. The case-control study comparing the two conditions found that urinary symptoms were one area where vascular parkinsonism patients actually fared worse than Parkinson’s patients.26PubMed Central. The clinical and neuroimaging differences between vascular parkinsonism and Parkinson’s disease: a case-control study If urinary urgency or incontinence appears alongside gait problems and vascular risk factors, that combination should raise the possibility of vascular parkinsonism rather than being dismissed as separate age-related issues.
The Mixed Pathology Problem
Perhaps the thorniest challenge in the field is that vascular pathology and neurodegenerative pathology coexist more often than anyone would like. Incidental vascular lesions in the brains of people with true Parkinson’s disease may be up to ten times more common than parkinsonism genuinely caused by cerebrovascular disease alone. This means that many people with Parkinson’s have vascular lesions on their scans that are bystanders, not drivers. Conversely, some people initially diagnosed with vascular parkinsonism turn out to have coexisting Parkinson’s pathology, which explains why they responded to levodopa.
The expert working group that formalized the diagnostic subtypes explicitly acknowledged this overlap by creating their third category: mixed or overlapping syndromes of vascular parkinsonism with Parkinson’s disease or other neurodegenerative parkinsonisms.27PubMed Central. An updated diagnostic approach to subtype definition of vascular parkinsonism – Recommendations from an expert working group This mixed group may actually be the most common real-world scenario, which is humbling. Clean diagnostic categories are useful for research and for structuring a clinical approach, but the brains of older people rarely cooperate with neat classification schemes. In practice, the neurologist is often managing a blend of pathologies and adjusting treatment based on which symptoms respond to which interventions.